Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
about
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in HumansDietary Capsaicin Protects Cardiometabolic Organs from DysfunctionNutritional modulation of endogenous glucagon-like peptide-1 secretion: a reviewReward-Induced Eating: Therapeutic Approaches to Addressing Food CravingsLorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.Relationship between Parental Feeding Practices and Neural Responses to Food Cues in Adolescents.Sex and estrogens alter the action of glucagon-like peptide-1 on reward.Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.Obese individuals with more components of the metabolic syndrome and/or prediabetes demonstrate decreased activation of reward-related brain centers in response to food cues in both the fed and fasting states: a preliminary fMRI study.Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double-blind, placebo-controlled, cross-over fMRI study.Brain reward responses to food stimuli among female monozygotic twins discordant for BMI.Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis.The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight.Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes.The safety of albiglutide for the treatment of type 2 diabetes.Semaglutide-the "new kid on the block" in the field of glucagon-like peptide-1 receptor agonists?GLP-1 and GLP-2 Levels are Correlated with Satiety Regulation After Roux-en-Y Gastric Bypass: Results of an Exploratory Prospective Study.Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study.Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.Phenotypes of Obesity: How it Impacts Management.Obese individuals with type 2 diabetes demonstrate decreased activation of the salience-related insula and increased activation of the emotion/salience-related amygdala to visual food cues compared to non-obese individuals with diabetes: A preliminar
P2860
Q26739671-8876FDF6-663D-41CA-BF12-DB2F89DEA055Q26749367-0A11E547-6D1A-4F6D-89B7-2782544CF0EAQ28070256-99A60044-5944-4224-AA21-BA62AD2B4C70Q28074195-61DEEE5A-75F4-4EE2-A3E5-4C584D9FBAA6Q34533195-175360A0-7C18-41C9-926A-FDEA77CC72CAQ36091581-12A44C67-C35F-4698-8B64-CFDB9B0C9B04Q36469127-3D1CFAFE-8216-4760-BE85-812C06D01431Q36495535-599FF1BE-A8A0-47A4-AC36-B2FE332E1761Q37685143-C2A68E66-C26B-4C96-91B8-9B99D3223332Q38118043-046D0738-3B7C-45A7-AA47-D754D757B3E9Q38673007-3DBE76AE-1309-45E5-BEC1-B5073DFEEAA7Q38753804-6432ADD8-C293-40A0-AEAC-AC301B149C52Q38850561-09952ADA-A4C0-4CAF-B3AD-07F16B86B8C7Q39205071-A72F546E-5B1E-4772-8E3B-F13492438D94Q39337620-12A0F7FF-979A-4EB9-A7CE-3E648CB34639Q39415439-DD16B696-FA7C-472D-AB90-52B783705E2FQ47097015-0F8E47CB-EADA-46FD-BFF7-17329F779FD5Q47403615-5B33A9EB-980A-4AEA-BE85-B5B8780EC93AQ48238552-A2AE6039-28C6-4370-B2BA-E008F0FD588BQ48588649-7512C051-5AC4-44A0-92A3-8B897DDBD0A7Q49834355-13EFD42B-B9A4-4461-9A67-4F66F8DCCA7DQ57136962-9B56E5C4-F099-4DB4-9C49-70AF7920626D
P2860
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@ast
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@en
type
label
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@ast
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@en
prefLabel
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@ast
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@en
P2093
P2860
P50
P1433
P1476
Endogenous GLP-1 mediates post ...... patients with type 2 diabetes
@en
P2093
Dick J Veltman
Jennifer S ten Kulve
John H Sloan
Liselotte van Bloemendaal
Madeleine L Drent
Michaela Diamant
Richard G IJzerman
Robert J Konrad
P2860
P2888
P304
P356
10.1007/S00125-015-3754-X
P577
2015-09-18T00:00:00Z